JCRB0526 TIG-101
Cell information
Important Notice(s)Notes for the cultivation of human normal diploid cells (JCRB05**) : ヒト正常二倍体細胞の取り扱い上の注意点
Cell type：general cells (View Pricing Information)
| JCRB No. | JCRB0526 | Cell Name | TIG-101 |
|---|---|---|---|
| Profile | Normal human diploid cell from skin | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | F | Age | 86 |
| Identity | available | Tissue for Primary Cancer | skin |
| Case history | normal | Metastasis | |
| Tissue Metastasized | Genetics | skin, normal diploid fibroblast | |
| Life Span | finite | Crisis PDL | |
| Morphology | fibroblast-like | Character | skin, normal diploid fibroblast |
| Classify | Established by | Yamamoto,K. | |
| Registered by | Ooka,H. | Regulation for Distribution | |
| Comment | Year | 1989 | |
| Medium | Eagle's minimal essential medium with 10% fetal bovine serum | Methods for Passages | Wash in CMF-PBS.Add 0.25% trypsin.Incubate at 37C for 10-15min.Suspend cells in medium. |
| Cell Number on Passage | 5x10^4 cells/cm^2 | Race | Japanese |
| CO2 Conc. | 5 % | Tissue Sampling | skin |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Images |
|---|
 |
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB0526 | Cell Name | |
|---|---|---|---|
| LOT No. | 06042007 | Lot Specification | distribution |
| Medium | Eagle's minimal essential medium with 10% fetal bovine serum (FBS lot; GIBCO 484375)This lot was frozen using DMSO. | Temperature | 37 C |
| Cell Density at Seeding | 1-3 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA. Split ratio =1:4 |
| Doubling Time | approx. 3-4 days | Cell Number in Vial (cells/1ml) | 6.3 x 10^5 |
| Viability at cell freezing (%) | 85.9 | Antibiotics Used | free |
| Passage Number | Unknown (7 at bank) | PDL | 34 |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), AST LD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - EMEM | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0526 | Cell Name | TIG-101 |
|---|---|---|---|
| LOT No. | 03242023 | Lot Specification | distribution |
| Medium | Eagle's minimum essential medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10437) | Temperature | 37 C |
| Cell Density at Seeding | 1.3 - 5.1 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. Split ratio = 1/4. |
| Doubling Time | approx. 4 days. | Cell Number in Vial (cells/1ml) | 8.0 x 10^5 |
| Viability at cell freezing (%) | approx. 100 | Antibiotics Used | free |
| Passage Number | Unknown (9 at bank) | PDL | 31.5 |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | D5S818:9,11 D13S317:9,10 D7S820:11,12 D16S539:11 VWA:14 TH01:6,7 AM:X TPOX:8,11 CSF1PO:9,12 |
|
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - EMEM | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 98 | Additional information |